Dynabeads™ Mouse CD4
Dynabeads™ Mouse CD4
Invitrogen™

Dynabeads™ Mouse CD4

Los Dynabeads™ CD4 de ratón son gránulos magnéticos que proporcionan una herramienta sólida y versátil para aislar o agotar célulasMás información
Have Questions?
Número de catálogoCantidad
11445D5 mL
Número de catálogo 11445D
Precio (MXN)
-
Cantidad:
5 mL
Los Dynabeads™ CD4 de ratón son gránulos magnéticos que proporcionan una herramienta sólida y versátil para aislar o agotar células T CD4+ de ratón directamente de cualquier muestra, incluidas digestiones de tejido tales como bazo o ganglios linfáticos, sangre completa, médula ósea y células mononucleares (MNC).
• Aislamiento rápido de células T CD4+ de ratón de cualquier muestra: no se necesitan columnas
• Aislamiento positivo para ensayos moleculares secuencia abajo o agotamiento eficaz de células T CD4+ de ratón

Excelente rendimiento, pureza y viabilidad de las células recuperadas
Los Dynabeads™ CD4 de ratón son gránulos superparamagnéticos uniformes (4,5 µm de diámetro) que permiten un fácil aislamiento de las células CD4+ de ratón del bazo o los ganglios linfáticos, aunque se puede utilizar cualquier suspensión de células individuales. Los Dynabeads™ CD4 de ratón están recubiertos con un anticuerpo monoclonal primario específico para el antígeno de la membrana de CD4, expresado principalmente en células T colaboradoras de ratón. Los Dynabeads™ CD4 de ratón se unen a las células CD4+ durante un corto periodo de incubación en un tubo, después del cual se separan las células unidas a gránulos de las células no unidas con un imán. Este método de aislamiento rápido y suave no requiere el uso de columnas, y ayuda a garantizar la alta pureza, recuperación y viabilidad de las células CD4+ aisladas.

Ideal tanto para el agotamiento como para el aislamiento positivo para ensayos moleculares secuencia abajo
Debido a los potentes imanes utilizados para la separación, los Dynabeads™ CD4 de ratón se pueden utilizar en muestras viscosas como suspensiones de células únicas de tejido, sangre completa y médula ósea, además de facilitar el agotamiento eficiente de las células CD4+ de ratón en unos 30 minutos. Los Dynabeads™ CD4 de ratón también permitirán una excelente recuperación de células viables de alta pureza para su uso en aislamiento positivo para estudios posteriores; por ejemplo, aquellos en los que las células deben ser lisadas mientras todavía están adheridas a gránulos y ácidos nucleicos o proteínas purificadas posteriormente. Tenga en cuenta que las células intactas no se liberarán de estos gránulos, por lo que, si desea aislar células CD4+ de ratón para aplicaciones basadas en células o necesita revisar sus muestras con citometría de flujo, debe usar DETACHaBEAD™ CD4 de ratón en combinación con estos productos (para células libres de gránulos y anticuerpos) o células CD4 Dynabeads™ FlowComp de ratón (kit completo para células libres de gránulos).

Seleccione la mejor opción de nuestra gama de productos de aislamiento de células CD4 de ratón.

Para uso exclusivo en investigación. No apto para uso diagnóstico o terapéutico en humanos ni en animales.
Para uso exclusivo en investigación. No apto para uso en procedimientos diagnósticos.
Especificaciones
Tipo de célulaCélulas T (CD4)
Tecnología de aislamientoAislamiento negativo
N.° de celdasProcesa ∼2x10^9 células en total
Viabilidad de la salida>95%
Línea de productosDYNAL, Dynabeads
Grado de pureza o calidadCalidad para investigación
Cantidad5 mL
ReactividadRatón
Tipo de muestraGanglio linfático, sangre, bazo
Condiciones de envíoTemperatura ambiente
N.º de celda del material de partida1 x 10^7 celdas por aislamiento
Especies dianaRatón
Diámetro (métrico)4,5 μm
Tipo de productoGránulo recubierto de anticuerpos
Unit SizeEach
Contenido y almacenamiento
Este producto contiene: 5 ml de Dynabeads™CD4 (L3T4) de ratón recubiertas con anticuerpo monoclonal anti-L3T4. El antígeno
L3T4 se expresa en los timocitos de ratón y los subconjuntos de
células T colaboradoras de células T maduras de las cepas de ratón más utilizadas.
Almacene entre 2 y 8 °C.

Preguntas frecuentes

My Dynabeads magnetic beads are not pelleting well with the magnet. Do you have any suggestions for me?

Please review the following possibilities for why your Dynabeads magnetic beads are not pelleting:

- The solution is too viscous.
- The beads have formed aggregates because of protein-protein interaction.

Try these suggestions: - Increase separation time (leave tub on magnet for 2-5 minutes)
- Add DNase I to the lysate (~0.01 mg/mL)
- Increase the Tween 20 concentration to ~0.05% of the binding and/or washing buffer.
- Add up to 20 mM beta-merecaptoethanol to the binding and/or wash buffers.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

I have a long double-stranded DNA fragment I would like to isolate. What product do you recommend?

For biotin-labeled DNA that is less than 1 kb, we recommend you use Dynabeads M270 Streptavidin (Cat. No. 65305) and MyOne C1 magnetic beads (Cat. No. 65001). We recommend our Dynabeads KilobaseBINDER Kit (Cat. No. 60101), which is designed to immobilize long (>1 kb) double-stranded DNA molecules. The KilobaseBINDER reagent consists of M-280 Streptavidin-coupled Dynabeads magnetic beads along with a patented immobilization activator in the binding solution to bind to long, biotinylated DNA molecules for isolation. Please see the following link (https://www.thermofisher.com/us/en/home/life-science/dna-rna-purification-analysis/napamisc/capture-of-biotinylated-targets/immobilisation-of-long-biotinylated-dna-fragments.html) for more information in regards to long biotinylated DNA fragment isolation.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

Can I use Dynabeads magnetic beads to isolate single-stranded DNA templates?

Yes, Dynabeads magnetic beads can be used to isolate single-stranded DNA. Streptavidin Dynabeads magnetic beads can be used to target biotinylated DNA fragments, followed by denaturation of the double-stranded DNA and removal of the non-biotinylated strand. The streptavidin-coupled Dynabeads magnetic beads will not inhibit any enzymatic activity. This enables further handling and manipulation of the bead-bound DNA directly on the solid phase. Please see the following link (https://www.thermofisher.com/us/en/home/life-science/dna-rna-purification-analysis/napamisc/capture-of-biotinylated-targets/preparing-single-stranded-dna-templates.html) for more information in regards to single-stranded DNA capture.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

What is the magnetic susceptibility for Dynabeads magnetic beads?

Magnetic susceptibility is a measure of how quickly the beads will migrate to the magnet. This will depend on the iron content and the character of the iron oxide. The magnetic susceptibility given for the Dynabeads magnetic beads is the mass susceptibility, given either as cgs units/g or m^3/kg (the latter being an SI unit). For ferri- and ferromagnetic substances, the magnetic mass susceptibility is dependent upon the magnetic field strength (H), as the magnetization of such substances is not a linear function of H but approaches a saturation value with increasing field. For that reason, the magnetic mass susceptibility of the Dynabeads magnetic beads is determined by a standardized procedure under fixed conditions. The magnetic mass susceptibility given in our catalog is thus the SI unit. Conversion from Gaussian (cgs, emu) units into SI units for magnetic mass susceptibility is achieved by multiplying the Gaussian factor (emu/g or cgs/g) by 4 pi x 10^-3. The resulting unit is also called the rationalized magnetic mass susceptibility, which should be distinguished from the (SI) dimensionless magnetic susceptibility unit. In general, magnetic mass susceptibility is a measure of the force (Fz) influencing an object positioned in a nonhomogenous magnetic field. The magnetic mass susceptibility of the Dynabeads magnetic beads is measured by weighing a sample, and then subjecting the sample to a magnetic field of known strength. The weight (F1) is then measured, and compared to the weight of the sample when the magnetic field is turned off (F0). The susceptibility is then calculated as K x 10^-3 = [(F1-F0) x m x 0.335 x 10^6], where K is the mass susceptibility of the sample of mass m. The susceptibility is then converted to SI units.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

How can I determine coupling efficiency of Dynabeads magnetic beads?

There are different methods to check binding of ligands to the beads, including optical density (OD) measurement, fluorescent labeling, and radioactive labeling.

For OD measurement, you would measure the OD of the ligand before immobilization to the beads and compare it with the ligand concentration that is left in the supernatant after coating. This gives a crude measurement of how much protein has bound to the beads.

Protocol:

1.Set spectrophotometer to the right wavelength. As a blank, use the Coupling Buffer.
2.Measure the absorbance of the Pre-Coupling Solution. A further dilution may be necessary to read the absorbance, depending upon the amount of ligand added.
3.Measure the absorbance of the Post-Coupling Solution. A dilution may be necessary to read the absorbance.
4.Calculate the coupling efficiency, expressed as the % protein uptake, as follows. [(Pre-Coupling Solution x D) - (Post-Coupling Solution x D)] x 100/(Pre-Coupling Solution x D) where D = dilution factor.

For fluorescent labeling, we suggest negatively quantifying the amount of ligand bound by measuring ligand remaining in the coupling supernatant (compared to the original sample), rather than directly measuring the ligands on the beads. Add labeled ligand to the beads, and measure how much ligand is left in the supernatant (not bound to the beads). By comparing this with the total amount added in the first place, you can then calculate how much of the ligand that has been bound to the beads. Keep in mind that the Dynabeads magnetic beads are also autofluorescent, which is why direct measuring of fluorescence of the bead-bound ligands is not recommended, but rather this indirect approach. The label could be, for example, FITC/PE. Some researchers perform a direct approach with success (using a flow cytometer).

Radioactive labeling is the most sensitive method of the three, but it is also the most difficult one. It involves radioactively labeling a portion of the ligand. We use radiolabeled I-125 in tracer amounts and mix it with "cold" ligands in a known ratio before coupling. The absolute quantities for the ligand on the beads should be obtained by measuring the beads in a scintillation (gamma) counter and comparing the cpm with a standard.

Protocol:

1.Take out an appropriate amount of beads and wash the beads in 1 mL of binding buffer.
2.Pipette out desired amount of human IgG in a separate tube.
3.Mix the human IgG with I-125-labeled human IgG (30,000 - 100,000 cpm).
4.Dilute the mixture of human IgG and I-125-labeled human IgG to 100 mL in binding buffer.
5.Incubate for 30 minutes at room temperature and measure the cpm in a scintillation counter.
6.Wash the beads (with coating) four times, and measure cpm again.
The % binding is calculated by using the equation : (cpm after washing/cpm before washing)x100%.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

Citations & References (7)

Citations & References
Abstract
Myeloid C3 determines induction of humoral responses to peripheral herpes simplex virus infection.
Authors:Verschoor A, Brockman MA, Gadjeva M, Knipe DM, Carroll MC,
Journal:J Immunol
PubMed ID:14607939
'The complement system, in addition to its role in innate immunity, is an important regulator of the B cell response. Complement exists predominantly in the circulation and although the primary source is hepatic, multiple additional cellular sources have been described that can contribute substantially to the complement pool. To date, ... More
Importance of group X-secreted phospholipase A2 in allergen-induced airway inflammation and remodeling in a mouse asthma model.
Authors:Henderson WR, Chi EY, Bollinger JG, Tien YT, Ye X, Castelli L, Rubtsov YP, Singer AG, Chiang GK, Nevalainen T, Rudensky AY, Gelb MH,
Journal:J Exp Med
PubMed ID:17403936
'Arachidonic acid metabolites, the eicosanoids, are key mediators of allergen-induced airway inflammation and remodeling in asthma. The availability of free arachidonate in cells for subsequent eicosanoid biosynthesis is controlled by phospholipase A(2)s (PLA(2)s), most notably cytosolic PLA(2)-alpha. 10 secreted PLA(2)s (sPLA(2)s) have also been identified, but their function in eicosanoid ... More
Antigen-specific CD8+ T cells respond to Chlamydia trachomatis in the genital mucosa.
Authors:Roan NR, Starnbach MN,
Journal:J Immunol
PubMed ID:17114470
Following sexual transmission, Chlamydia trachomatis specifically targets genital tract epithelial cells. Because epithelial cells are readily recognized by CD8+ T cells, the response of CD8+ T cells to Chlamydia infection has been explored in a number of studies. It has been shown that CD8+ T cells are present in the ... More
Immunization with murine breast cancer cells treated with antisense oligodeoxynucleotides to type I insulin-like growth factor receptor induced an antitumoral effect mediated by a CD8+ response involving Fas/Fas ligand cytotoxic pathway.
Authors:Schillaci R, Salatino M, Cassataro J, Proietti CJ, Giambartolomei GH, Rivas MA, Carnevale RP, Charreau EH, Elizalde PV,
Journal:J Immunol
PubMed ID:16517711
We have demonstrated that in vivo administration of phosphorothioate antisense oligodeoxynucleotides (AS[S]ODNs) to type I insulin-like growth factor receptor (IGF-IR) mRNA resulted in inhibition of C4HD breast cancer growth in BALB/c mice. The present study focused on whether in vivo administration of C4HD tumor cells pretreated with IGF-IR AS[S]ODN and ... More
Tumor regression induced by intratumor therapy with a disabled infectious single cycle (DISC) herpes simplex virus (HSV) vector, DISC/HSV/murine granulocyte-macrophage colony-stimulating factor, correlates with antigen-specific adaptive immunity.
Authors:Ali SA, Lynam J, McLean CS, Entwisle C, Loudon P, Rojas JM, McArdle SE, Li G, Mian S, Rees RC,
Journal:J Immunol
PubMed ID:11907113
Direct intratumor injection of a disabled infectious single cycle HSV-2 virus encoding the murine GM-CSF gene (DISC/mGM-CSF) into established murine colon carcinoma CT26 tumors induced a significant delay in tumor growth and complete tumor regression in up to 70% of animals. Pre-existing immunity to HSV did not reduce the therapeutic ... More